189096
Integration across Programs: The Synchronicities
Wednesday, October 29, 2008: 9:05 AM
Susan DeLisle, ARNP MPH
,
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA
Program Collaboration and Service Integration (PCSI) is a major strategic priority for the National Center for HIV/AID, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) at the Centers for Disease Control and Prevention (CDC). PCSI focuses on integrated service delivery at the client level. There are several factors creating momentum toward greater integration of prevention services including advances in diagnostic technology and treatment, similar or overlapping at-risk populations, disease interactions, social determinants of health, and similar prevention strategies. Barriers to integration cited by programs include administrative and fiscal inflexibilities due to “siloed” funding, lack of harmony and synchronization of data collection and surveillance systems, and gaps in translation and integration of science and program. This presentation will focus on the strategies being employed to identify where service integration is likely to lead to the greatest public health impact and the program research questions of highest priority to advancing program collaboration and service integration
Learning Objectives: 1. Articulate the vision and operating definition of Program Collaboration and Service Integration.
2. Differentiate between program components that need to remain vertical and those that can be coordinated or integrated.
3. Identify program science questions that can inform program integration.
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I am the Associate Director for Program Integration within the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|